Images: Detection of immunoreactive CD39 and CD73 in the effluent of ischemia reperfusion. The effluent samples (300 μl) from pre-ischemia (3) and ischemia-reperfusion hearts (4) were applied to nitrocellulose membrane, and subjected to dot blot analysis with anti-CD39 antibody (A) and anti-CD73 antibody (B). As the negative and positive control, membrane extract (30 μg protein in 300 μl) from HEK293 cells transfected with control pcDNA3vector (1 in A and B) or CD39- (2 in A) and CD73-expressing plasmid (2 in B) were used. Results shown are representative of three separate sets of experiments. Takahashi-Sato et al. BMC Cardiovascular Disorders 2013 13:53 doi:10.1186/1471-2261-13-5
- Product Reviews
- Product Publications
If you've used this product in a publication, let us know. Email firstname.lastname@example.org, with the publication details and you could be eligible for an Amazon gift card.
- Related Products